HINALBEN PATEL: Open Payments
NPI 1801528658 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,797 in 99 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $2,311 · 2025 $1,797
Food & beverage: $1,797
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 21 | $330 |
| ARGENX US, INC. | 8 | $168 |
| PFIZER INC. | 18 | $165 |
| UCB, Inc. | 7 | $124 |
| Celgene Corporation | 5 | $98 |
| Alexion Pharmaceuticals, Inc. | 3 | $92 |
| SK Life Science, Inc. | 4 | $87 |
| Biogen, Inc. | 4 | $83 |
| ACADIA Pharmaceuticals Inc | 3 | $82 |
| Merz Pharmaceuticals, LLC | 3 | $76 |
Products named: KESIMPTA, VYVGART HYTRULO, NURTEC ODT, ZEPOSIA, ULTOMIRIS, NUPLAZID, Xeomin, Briviact.
Industry payments across TN — which companies pay providers there.
